Results 191 to 200 of about 36,609,695 (340)

Patient satisfaction and performance of the A8+ TouchCare Nano in children and adolescents with type 1 diabetes mellitus. [PDF]

World J Clin Pediatr
Kosta K, Grammatikopoulou MG, Toulia I, Smyrnaki P, Paschalidou EG, Vamvakis A, Bogiatzoglou A, Tzimos C, Tsiroukidou K.   +8 more
europepmc   +1 more source

Gamified learning meets physiology: Healthcare students' gameful experience with a virtual educational escape room

Anatomical Sciences Education, EarlyView.
Abstract Gamified teaching approaches are increasingly used in higher education, making it essential to examine the gameful experience resulting from interaction with educational game elements. This study aimed to evaluate undergraduate health science students' gamified learning experience using the Gamified Experience Measurement Scale in Education ...
David Martin‐Hidalgo, Guadalupe Álvarez‐Hernán, Cristina Carrasco Romero, Violeta Calle‐Guisado   +3 more
wiley   +1 more source

Factors associated with food insecurity in children and adolescents with type 1 diabetes mellitus. [PDF]

J Pediatr (Rio J)
Pinto GFT, Braga JSDN, Mathias ABGA, Sizisnande PM, Rodrigues PHV, Luescher J, Padilha PC.   +6 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Frequency of autoimmune diseases in children and adolescents with type 1 diabetes mellitus. [PDF]

Front Endocrinol (Lausanne)
Yaman Ortakoylu M, Gonc EN, Ozon A, Kandemir N, Alikasifoglu A.   +4 more
europepmc   +1 more source

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source

New and emerging therapies in type 1 diabetes mellitus. [PDF]

J Clin Invest
Herold KC, Evans-Molina C.
europepmc   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Health Literacy and Type 1 Diabetes Mellitus: A Mixed Method Study. [PDF]

Health Lit Res Pract
Kortegaard AS, Andersen A, Aastrup AE, Sandersen HR, Jensen AL.   +4 more
europepmc   +1 more source

Remote Screening for Age‐Related Olfactory Dysfunction Using the 4‐Item Concise Aging Adults Smell Test

International Forum of Allergy &Rhinology, EarlyView.
Zachary M. Soler, Daniel Giles, Mathew J. Gregoski, Rodney J. Schlosser   +3 more
wiley   +1 more source